Nishant Goel
About Nishant Goel
Data last updated:
Nishant Goel has 16 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Ekana Health Products Llp and Status Pharmaceuticals Private Limited. Formerly with 2 companies, such as Manya Infrabuildwell Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Ekana Health Products Llp AAS-5960 | Designated Partner | 12 Jun 2020 | 2020 | Active |
 Croford Healthcare Private Limited U93030UP2011PTC045910 | Director | 27 Jul 2011 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Manya Infrabuildwell Private Limited U70102UP2012PTC052445 | Director | 25 Apr 2013 | 2012 | Active |
| Status Pharmaceuticals Private Limited U24233DL2010PTC201016 | Director | 31 Mar 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nishant Goel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nishant Goel
Nishant Goel has 16 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Ekana Health Products Llp and Status Pharmaceuticals Private Limited. Formerly with 2 companies, such as Manya Infrabuildwell Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Nishant Goel is associated with 2 companies as Designated Partner and Director.
Nishant Goel has expertise in Healthcare, General Business.
Nishant Goel has 16 years in corporate governance.